Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Camm

Showing results (81-90 of 662) with videos related to

Pageof 67
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 23, 2025
A double paradox: end-stage renal disease-high thromboembolic and bleeding risk management using a device with risks of thromboembolism and bleedingTatjana Potpara, A John Camm
European Heart Journal|September 2, 2014
Vagal nerve stimulation in heart failureA John Camm, Irina Savelieva
Cardiology|November 13, 2019
A New Biomarker in Atrial Fibrillation: Monocyte Chemoattractant Protein-1-Induced ProteinIrina Savelieva, A John Camm
Heart Rhythm|April 27, 2005
Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?A John Camm, Irina Savelieva
Pacing and Clinical Electrophysiology : PACE|December 17, 2003
Quinolones: cardioprotective or cardiotoxicDemosthenes Katritsis, A John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2021
Should we make the risk stratification process more complex in patients with atrial fibrillation? Authors' replyCarlos Escobar, A John Camm
Circulation|September 9, 2011
Fish oil for secondary prevention of atrial fibrillation: should we still believe in its antiarrhythmic effect?A John Camm, Irina Savelieva
Drug Safety|January 26, 2008
I f inhibition with ivabradine : electrophysiological effects and safetyIrina Savelieva, A John Camm
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
The sinus tachycardiasShamil Yusuf, A John Camm
The Practitioner|August 2, 2008
Diagnosing patients with supraventricular tachycardiaMalini Govindan, A John Camm
Pageof 67

Showing results (81-90 of 662) with videos related to

Sort By:
Pageof 67
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 23, 2025
A double paradox: end-stage renal disease-high thromboembolic and bleeding risk management using a device with risks of thromboembolism and bleedingTatjana Potpara, A John Camm
European Heart Journal|September 2, 2014
Vagal nerve stimulation in heart failureA John Camm, Irina Savelieva
Cardiology|November 13, 2019
A New Biomarker in Atrial Fibrillation: Monocyte Chemoattractant Protein-1-Induced ProteinIrina Savelieva, A John Camm
Heart Rhythm|April 27, 2005
Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?A John Camm, Irina Savelieva
Pacing and Clinical Electrophysiology : PACE|December 17, 2003
Quinolones: cardioprotective or cardiotoxicDemosthenes Katritsis, A John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2021
Should we make the risk stratification process more complex in patients with atrial fibrillation? Authors' replyCarlos Escobar, A John Camm
Circulation|September 9, 2011
Fish oil for secondary prevention of atrial fibrillation: should we still believe in its antiarrhythmic effect?A John Camm, Irina Savelieva
Drug Safety|January 26, 2008
I f inhibition with ivabradine : electrophysiological effects and safetyIrina Savelieva, A John Camm
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
The sinus tachycardiasShamil Yusuf, A John Camm
The Practitioner|August 2, 2008
Diagnosing patients with supraventricular tachycardiaMalini Govindan, A John Camm
Pageof 67